Movement disorders and alcohol misuse

Addiction Biology

Volumn 11, Issue 2, 2006, Pages 117-125

  Hess, Christopher W ^c   Saunders Pullman, Rachel ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c PACC ^*

Author keywords

Abuse; Alcohol; Epsilon sarcoglycan; Essential tremor; Movement disorders; Myoclonus dystonia

Indexed keywords

ALCOHOL; 4 AMINOBUTYRIC ACID; CENTRAL DEPRESSANT AGENT; OXYBATE SODIUM;

ALCOHOL CONSUMPTION; ALCOHOLISM; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 7Q; COMORBIDITY; DELAYED NEUROTOXICITY; DYSTONIA; ESSENTIAL TREMOR; HUMAN; LINKAGE ANALYSIS; MOTOR DYSFUNCTION; MYOCLONUS; NEUROLOGICAL COMPLICATION; NEUROMODULATION; PENETRANCE; PRIORITY JOURNAL; REVIEW; SELF MEDICATION; SUBSTANCE ABUSE; BRAIN; DRINKING BEHAVIOR; DRUG EFFECT; EXON; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; POINT MUTATION;

ADJUVANTS, ANESTHESIA; ALCOHOL DRINKING; BRAIN; COMORBIDITY; DYSTONIC DISORDERS; ESSENTIAL TREMOR; ETHANOL; EXONS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MOVEMENT DISORDERS; MYOCLONUS; PHENOTYPE; POINT MUTATION; SELF MEDICATION; SODIUM OXYBATE;

EID: 33847028979     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2006.00017.x     Document Type: Review

References (94)

1. Ariwodola OJ, Weiner JL (2004) Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J Neurosci 24: 10679 10686.
2. Asmus F, Zimprich A, Naumann M, Berg D, Bertram M, Ceballos-Baumann A, Pruszak-Seel R, Kabus C, Dichgans M, Fuchs S, Muller-Myhsok B, Gasser T (2001) Inherited myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol 49: 121 124.
3. Asmus F, Zimprich A, Tezenas Du Montcel S, Kabus C, Deuschl G, Kupsch A, Ziemann U, Castro M, Kuhn AA, Strom TM, Vidailhet M, Bhatia KP, Durr A, Wood NW, Brice A, Gasser T (2002) Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol 52: 489 492.
4. Bain PG, Findley LJ, Thompson PD, Gresty MA, Rothwell JC, Harding AE, Marsden CD (1994) A study of hereditary essential tremor. Brain 117: 805 824.
5. Bartolomei F, Azulay JP, Barrie M, Gastaut JL (1996) Myoclonic alcoholic epilepsy. Epilepsia 37: 406 409.
6. Boecker H, Wills AJ, Ceballos-Baumann A, Samuel M, Thompson PD, Findley LJ, Brooks DJ (1996) The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol 39: 650 658.
7. Borges V, Ferraz HB, de Andrade LA (2000) Alcohol-sensitive hereditary essential myoclonus with dystonia: a study of 6 Brazilian patients. Neurol Sci 21: 373 377.
8. Bushara KO, Goldstein SR, Grimes GJ Jr, Burstein AH, Hallett M (2004) Pilot trial of 1-octanol in essential tremor. Neurology 62: 122 124.
9. Chan P, Gonzalez-Maeso J, Ruf F, Bishop DF, Hof PR, Sealfon SC (2005) Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain. J Comp Neurol 482: 50 73.
10. Choy-Kwong M, Lipton RB (1989) Dystonia related to cocaine withdrawal: a case report and pathogenic hypothesis. Neurology 39: 996 997.
11. Critchley M (1949) Observations on essential (heredo-familial) tremor. Brain 72: 113 139.
12. Daras M, Koppel BS, Atos-Radzion E (1994) Cocaine-induced choreoathetoid movements ('crack dancing'). Neurology 44: 751 752.
13. Deuschl G, Elble RJ (2000) The pathophysiology of essential tremor. Neurology 54: S14 S20.
14. Doheny DO, Brin MF, Morrison CE, Smith CJ, Walker RH, Abbasi S, Muller B, Garrels J, Liu L, De Carvalho Aguiar P, Schilling K, Kramer P, De Leon D, Raymond D, Saunders-Pullman R, Klein C, Bressman SB, Schmand B, Tijssen MA, Ozelius LJ, Silverman JM (2002) Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 59: 1187 1196.
15. Dubinsky RM, Hallett M (1987) Glucose hypermetabolism of the inferior olive in patients with essential tremor. Ann Neurol 22: 118.
16. den Dunnen JT (2005) Complete Allelic Variant Table, Epsilon-Sarcoglycan Sequence Variations. Leiden: Leiden University Medical Center. Available at http://www.dmd.nl/sgce_seqvar.html. Accessed 8 August 2005.
17. Duvoisin RC (1984) Essential myoclonus: response to anticholinergic therapy. Clin Neuropharmacol 7: 141 147.
18. Elble RJ (2000) Essential tremor frequency decreases with time. Neurology 55: 1547 1551.
19. Evidente VG (2000) Understanding essential tremor. Differential diagnosis and options for treatment. Postgrad Med 108: 138 140, 143 136, 149.
20. Fahn S, Sjaastad O (1991) Hereditary essential myoclonus in a large Norwegian family. Mov Disord 6: 237 247.
21. Farrer M, Gwinn-Hardy K, Muenter M, DeVrieze FW, Crook R, Perez-Tur J, Lincoln S, Maraganore D, Adler C, Newman S, MacElwee K, McCarthy P, Miller C, Waters C, Hardy J (1999) A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 8: 81 85.
22. Findley LJ (2000) Epidemiology and genetics of essential tremor. Neurology 54: S8 S13.
23. Frucht SJ, Bordelon Y, Houghton WH, Reardan D (2005) A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord 20: 1330 1337.
24. Gasser T, Bereznai B, Muller B, Pruszak-Seel R, Damrich R, Deuschl G, Oertel WH (1996) Linkage studies in alcohol-responsive myoclonic dystonia. Mov Disord 11: 363 370.
25. Grimes DA (2003) Tremor - easily seen but difficult to describe and treat. Can J Neurol Sci 30: S59 S63.
26. Grimes DA, Bulman D, George-Hyslop PS, Lang AE (2001) Inherited myoclonus-dystonia: evidence supporting genetic heterogeneity. Mov Disord 16: 106 110.
27. Grimes DA, Han F, Lang AE, St George-Hyssop P, Racacho L, Bulman DE (2002) A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 59: 1183 1186.
28. Growdon JH, Shahani BT, Young RR (1975) The effect of alcohol on essential tremor. Neurology 25: 259 262.
29. Gulcher JR, Jonsson P, Kong A, Kristjansson K, Frigge ML, Karason A, Einarsdottir IE, Stefansson H, Einarsdottir AS, Sigurthoardottir S, Baldursson S, Bjornsdottir S, Hrafnkelsdottir SM, Jakobsson F, Benedickz J, Stefansson K (1997) Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nat Genet 17: 84 87.
30. Habal R, Sauter D, Olowe O, Daras M (1991) Cocaine and chorea. Am J Emerg Med 9: 618 620.
31. Hallett M, Dubinsky RM (1993) Glucose metabolism in the brain of patients with essential tremor. J Neurol Sci 114: 45 48.
32. Han F, Lang AE, Racacho L, Bulman DE, Grimes DA (2003) Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families. Neurology 61: 244 246.
33. Hedrich K, Meyer EM, Schule B, Kock N, de Carvalho Aguiar P, Wiegers K, Koelman JH, Garrels J, Durr R, Liu L, Schwinger E, Ozelius LJ, Landwehrmeyer B, Stoessl AJ, Tijssen MA, Klein C (2004) Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. Neurology 62: 1229 1231.
34. Higgins JJ, Pho LT, Nee LE (1997) A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov Disord 12: 859 864.
35. Hjermind LE, Werdelin LM, Eiberg H, Krag-Olsen B, Dupont E, Sorensen SA (2003) A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome. Neurology 60: 1536 1539.
36. Jankovic J, Madisetty J, Vuong KD (2004) Essential tremor among children. Pediatrics 114: 1203 1205.
37. Jankovic J, Noebels JL (2005) Genetic mouse models of essential tremor: are they essential? J Clin Invest 115: 584 586.
38. Jenkins IH, Bain PG, Colebatch JG, Thompson PD, Findley LJ, Frackowiak RS, Marsden CD, Brooks DJ (1993) A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol 34: 82 90.
39. Klebe S, Stolze H, Grensing K, Volkmann J, Wenzelburger R, Deuschl G (2005) Influence of alcohol on gait in patients with essential tremor. Neurology 65: 96 101.
40. Klein C, Brin MF, Kramer P, Sena-Esteves M, de Leon D, Doheny D, Bressman S, Fahn S, Breakefield XO, Ozelius LJ (1999) Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci USA 96: 5173 5176.
41. Klein C, Gurvich N, Sena-Esteves M, Bressman S, Brin MF, Ebersole BJ, Fink S, Forsgren L, Friedman J, Grimes D, Holmgren G, Kyllerman M, Lang AE, de Leon D, Leung J, Prioleau C, Raymond D, Sanner G, Saunders-Pullman R, Vieregge P, Wahlstrom J, Breakefield XO, Kramer PL, Ozelius LJ, Sealfon SC (2000a) Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia. Ann Neurol 47: 369 373.
42. Klein C, Liu L, Doheny D, Kock N, Muller B, de Carvalho Aguiar P, Leung J, de Leon D, Bressman SB, Silverman J, Smith C, Danisi F, Morrison C, Walker RH, Velickovic M, Schwinger E, Kramer PL, Breakefield XO, Brin MF, Ozelius LJ (2002) Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann Neurol 52: 675 679.
43. Klein C, Schilling K, Saunders-Pullman RJ, Garrels J, Breakefield XO, Brin MF, deLeon D, Doheny D, Fahu S, Fink JS, Forsgren L, Friedman J, Frucht S, Harris J, Holmgren G, Kis B, Kurlan R, Kallermak M, Lang AE, Leung J, Raymond D, Robishaw JD, Sanner G, Schwinger E, Tabamo RE, Tagliati M (2000b) A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet 67: 1314 1319.
44. Koller WC (1983) Alcoholism in essential tremor. Neurology 33: 1074 1076.
45. Koller WC (1991) A new drug for treatment of essential tremor? Time will tell. Mayo Clin Proc 66: 1085 1087.
46. Koller WC, Hristova A, Brin M (2000) Pharmacologic treatment of essential tremor. Neurology 54: S30 S38.
47. Kovach MJ, Ruiz J, Kimonis K, Mueed S, Sinha S, Higgins C, Elble S, Elble R, Kimonis VE (2001) Genetic heterogeneity in autosomal dominant essential tremor. Genet Med 3: 197 199.
48. Kralic JE, Criswell HE, Osterman JL, O'Buckley TK, Wilkie ME, Matthews DB, Hamre K, Breese GR, Homanics GE, Morrow AL (2005) Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest 115: 774 779.
49. Kurlan R, Behr J, Medved L, Shoulson I (1988) Myoclonus and dystonia: a family study. Adv Neurol 50: 385 389.
50. Kyllerman M, Forsgren L, Sanner G, Holmgren G, Wahlstrom J, Drugge U (1990) Alcohol-responsive myoclonic dystonia in a large family: dominant inheritance and phenotypic variation. Mov Disord 5: 270 279.
51. Langston JW (2002) Parkinson's disease: current and future challenges. Neurotoxicology 23: 443 450.
52. Lim LE, Campbell KP (1998) The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol 11: 443 452.
53. Loewenstein Y (2002) A possible role of olivary gap-junctions in the generation of physiological and pathological tremors. Mol Psychiatry 7: 129 131.
54. Lopez W, Jeste DV (1997) Movement disorders and substance abuse. Psychiatr Serv 48: 634 636.
55. Louis ED, Barnes LF, Ford B, Pullman SL, Yu Q (2000) Ethnic differences in essential tremor. Arch Neurol 57: 723 727.
56. Louis ED, Ford B, Frucht S, Barnes LF, Tang MX, Ottman R (2001) Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol 49: 761 769.
57. Louis ED, Shungu DC, Chan S, Mao X, Jurewicz EC, Watner D (2002a) Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett 333: 17 20.
58. Louis ED, Zheng W, Jurewicz EC, Watner D, Chen J, Factor-Litvak P, Parides M (2002b) Elevation of blood beta-carboline alkaloids in essential tremor. Neurology 59: 1940 1944.
59. Mahloudji M, Pikielny RT (1967) Hereditary essential myoclonus. Brain 90: 669 674.
60. Marechal L, Raux G, Dumanchin C, Lefebvre G, Deslandre E, Girard C, Campion D, Parain D, Frebourg T, Hannequin D (2003) Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet 119B: 114 117.
61. Marsden CD, Hallet M, Fahn S (1982) The nosology and pathophysiology of myoclonus. In: Marsden CD Fahn S, eds. Movement Disorders, pp. 196 248. London: Butterworths.
62. Muller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, Landt O, Nitschke M, Pramstaller PP, Reik W, Schwinger E, Sperner J, Ozelius L, Kostic V, Klein C (2002) Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 71: 1303 1311.
63. Mullin PJ, Kershaw PW, Bolt JM (1970) Choreoathetotic movement disorder in alcoholism. Br Med J 4: 278 281.
64. Nasrallah HA, Schroeder D, Petty F (1982) Alcoholism secondary to essential tremor. J Clin Psychiatry 43: 163 164.
65. Neiman J, Lang AE, Fornazzari L, Carlen PL (1990) Movement disorders in alcoholism: a review. Neurology 40: 741 746.
66. Nygaard TG, Raymond D, Chen C, Nishino I, Greene PE, Jennings D, Heiman GA, Klein C, Saunders-Pullman RJ, Kramer P, Ozelius LJ, Bressman SB (1999) Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol 46: 794 798.
67. Pagan FL, Butman JA, Dambrosia JM, Hallett M (2003) Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 60: 1344 1347.
68. Pascual-Leone A, Dhuna A (1990) Cocaine-associated multifocal tics. Neurology 40: 999 1000.
69. Priori A, Bertolasi L, Pesenti A, Cappellari A, Barbieri S (2000) gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia. Neurology 54: 1706.
70. Quinn NP (1996) Essential myoclonus and myoclonic dystonia. Mov Disord 11: 119 124.
71. Rautakorpi I, Marttila RJ, Rinne UK (1983) Alcohol consumption of patients with essential tremor. Acta Neurol Scand 68: 177 179.
72. Rhee KJ, Albertson TE, Douglas JC (1988) Choreoathetoid disorder associated with amphetamine-like drugs. Am J Emerg Med 6: 131 133.
73. Saunders-Pullman R, Ozelius L, Bressman SB (2002a) Inherited myoclonus-dystonia. Adv Neurol 89: 185 191.
74. Saunders-Pullman R, Shriberg J, Heiman G, Raymond D, Wendt K, Kramer P, Schilling K, Kurlan R, Klein C, Ozelius LJ, Risch NJ, Bressman SB (2002b) Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 58: 242 245.
75. Schroeder D, Nasrallah HA (1982) High alcoholism rate in patients with essential tremor. Am J Psychiatry 139: 1471 1473.
76. Schule B, Kock N, Svetel M, Dragasevic N, Hedrich K, De Carvalho Aguiar P, Liu L, Kabakci K, Garrels J, Meyer EM, Berisavac I, Schwinger E, Kramer PL, Ozelius LJ, Klein C, Kostic V (2004) Genetic heterogeneity in ten families with myoclonus-dystonia. J Neurol Neurosurg Psychiatry 75: 1181 1185.
77. Secil Y, Gokcay A, Ekmekci O, Karasoy H, Ulku A (2001) Hereditary essential myoclonus: report of a family. Journal of Neurological Sciences (Turkish) 18: 31. Available at http://norolbil.ege.edu.tr/2001/2001_3.html. Accessed 25 June 2003.
78. Shill HA, Bushara KO, Mari Z, Reich M, Hallett M (2004) Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 62: 2320 2322.
79. Sinton CM, Krosser BI, Walton KD, Llinas RR (1989) The effectiveness of different isomers of octanol as blockers of harmaline-induced tremor. Pflugers Arch 414: 31 36.
80. Solomon JG (1983) Alcoholism and essential tremor in VA patients. Am J Psychiatry 140: 671.
81. Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G (2001) The gait disorder of advanced essential tremor. Brain 124: 2278 2286.
82. Tanner CM, Goldman SM, Lyons KE, Aston DA, Tetrud JW, Welsh MD, Langston JW, Koller WC (2001) Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology 57: 1389 1391.
83. Uitti RJ, Snow BJ, Shinotoh H, Vingerhoets FJ, Hayward M, Hashimoto S, Richmond J, Markey SP, Markey CJ, Calne DB (1994) Parkinsonism induced by solvent abuse. Ann Neurol 35: 616 619.
84. Valente EM, Edwards MJ, Mir P, DiGiorgio A, Salvi S, Davis M, Russo N, Bozi M, Kim HT, Pennisi G, Quinn N, Dallapiccola B, Bhatia KP (2005) The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 64: 737 739.
85. Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, Salvi S, Nemeth A, Shaw-Smith C, Nardocci N, Bentivoglio AR, Berardelli A, Eleopra R, Dallapiccola B, Warner TT (2003) Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord 18: 1047 1051.
86. Vidailhet M, Tassin J, Durif F, Nivelon-Chevallier A, Agid Y, Brice A, Durr A (2001) A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology 56: 1213 1216.
87. Wills AJ, Jenkins IH, Thompson PD, Findley LJ, Brooks DJ (1994) Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann Neurol 36: 636 642.
88. Wills AJ, Jenkins IH, Thompson PD, Findley LJ, Brooks DJ (1995) A positron emission tomography study of cerebral activation associated with essential and writing tremor. Arch Neurol 52: 299 305.
89. Wilms H, Sievers J, Deuschl G (1999) Animal models of tremor. Mov Disord 14: 557 571.
90. Wu Y, Ali S, Ahmadian G, Liu CC, Wang YT, Gibson KM, Calver AR, Francis J, Pangalos MN, Snead OC (2004) Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence. Neuropharmacology 47: 1146 1156.
91. Xiao J, LeDoux MS (2003) Cloning, developmental regulation and neural localization of rat epsilon-sarcoglycan. Brain Res Mol Brain Res 119: 132 143.
92. Zesiewicz TA, Elble R, Louis ED, Hauser RA, Sullivan KL, Dewey RB Jr, Ondo WG, Gronseth GS, Weiner WJ (2005) Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 64: 2008 2020.
93. Zeuner KE, Molloy FM, Shoge RO, Goldstein SR, Wesley R, Hallett M (2003) Effect of ethanol on the central oscillator in essential tremor. Mov Disord 18: 1280 1285.
94. Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, Muller-Myhsok B, Riedel L, Bauer M, Muller T, Castro M, Meitinger T, Strom TM, Gasser T (2001) Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29: 66 69.